Nomogram Based on Risk Factors for Type 2 Diabetes Mellitus Patients with Coronary Heart Disease

References

• IDF. Available from: https://diabetesatlas.org/en/. Accessed December 10, 2020.
   Google Scholar
• International Diabetes Federation IDF Diabetes Atlas. Epidemiology and morbidity. Available from: https://diabetesatlas.org/en/.Accessed December 10, 2020.
   Google Scholar
• Ramachandran A, Ma RCW, Snehalatha C. Diabetes in asia. Lancet. 2010;375(9712):408–418. doi:10.1016/S0140-6736(09)60937-5
   PubMed Web of Science ®Google Scholar
• Hu H, Sawhney M, Shi L. A systematic review of the direct economic burden of type 2 diabetes in China. Diabetes Ther. 2015;6(1):7–16. doi:10.1007/s13300-015-0096-0
   PubMed Web of Science ®Google Scholar
• Dal Canto E, Ceriello A, Ryden L, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2_SUPPL):25–32. doi:10.1177/2047487319878371
   PubMed Web of Science ®Google Scholar
• Anand SS, Dagenais GR, Mohan V, et al. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Prev Cardiol. 2012;19(4):755–764. doi:10.1177/1741826711409327
   PubMedGoogle Scholar
• Ali A, Abu Zar M, Kamal A, et al. American heart association high blood pressure protocol 2017: a literature review. Cureus. 2018;10(8):e3230–e3230.
   PubMed Web of Science ®Google Scholar
• Gaman M-A, Cozma M-A, Dobrica E-C, Bacalbasa N, Bratu OG, Diaconu CC. Dyslipidemia: a trigger for coronary heart disease in Romanian patients with diabetes. Metabolites. 2020;10(5):195. doi:10.3390/metabo10050195
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Kamyar MR, Gerhat D, et al. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus. Gend Med. 2010;7(6):571–583. doi:10.1016/j.genm.2010.12.001
   PubMedGoogle Scholar
• Cikim G, Canatan H, Gursu MF, Gulcu F, Baydas G, Kilicoglu AE. Levels of zinc and lipid peroxidation in acute coronary syndrome. Biol Trace Elem Res. 2003;96(1–3):61–69. doi:10.1385/BTER:96:1-3:61
   PubMedGoogle Scholar
• Wu J, Xun P, Tang Q, Cai W, He K. Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Nutr J. 2017;16.
   PubMedGoogle Scholar
• Li W, Xie B, Qiu SH, et al. Non-lab and semi-lab algorithms for screening undiagnosed diabetes: a cross-sectional study. EBioMedicine. 2018;35:307–316. doi:10.1016/j.ebiom.2018.08.009
   PubMed Web of Science ®Google Scholar
• Wang HJ, Zhang L, Liu Z, et al. Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram. Patient Prefer Adherence. 2018;12:1757–1765. doi:10.2147/PPA.S159293
   PubMed Web of Science ®Google Scholar
• Huang. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer (vol 34, pg 2157, 2016). J Clin Oncol. 2016;34(20):2435.
   Google Scholar
• Chen L, Wei B, Xu L, Wu Y. The association of inflammatory markers and periodontal indexes with the risk of coronary heart disease in Chinese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2018:S0168822717313372.
   Google Scholar
• Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):19. doi:10.1186/s12933-018-0728-6
   PubMedGoogle Scholar
• Xiao H, Du AM, Yun P, Zhang HF, Tian Y, Xiao FX. Prevalence and risk factors of chronic complications of type 2 diabetic inpatients in Hubei Province of central China: results from a multiple-hospital study. Int J Diabetes Dev Ctries. 2016;36(2):242–247. doi:10.1007/s13410-015-0452-7
   Web of Science ®Google Scholar
• Iglay K, Hannachi H, Howie PJ, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016:1–44.
   Google Scholar
• Dodos I, Georgopoulos S, Dodos K, et al. Correlation of glycosylated hemoglobin levels with histological and ultrasound characteristics of the carotid plaque in diabetic and nondiabetic patients. Ann Vasc Surg. 2019;61:218–226. doi:10.1016/j.avsg.2019.04.013
   PubMedGoogle Scholar
• Pang X-H, Han J, Ye W-L, et al. Lower extremity peripheral arterial disease is an independent predictor of coronary heart disease and stroke risks in patients with type 2 diabetes mellitus in China. Int J Endocrinol. 2017;2017:9620513. doi:10.1155/2017/9620513
   PubMedGoogle Scholar
• Wu Y, He J, Sun X, et al. Carotid atherosclerosis and its relationship to coronary heart disease and stroke risk in patients with type 2 diabetes mellitus. Medicine. 2017;96:39.
   Google Scholar
• Ramachandran A, Snehalatha C, Satyavani K, Latha E, Sasikala R, Vijay V. Prevalence of vascular complications and their risk factors in type 2 diabetes. J Assoc Physicians India. 1999;47(12):1152.
   PubMedGoogle Scholar
• Baluja A, Rodriguez-Manero M, Cordero A, et al. Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome. Diabetes Vasc Dis Res. 2020;8.
   Google Scholar
• Dodos I, Georgopoulos S, Dodos K, et al. Correlation of glycosylated hemoglobin (HbA1c) levels with histological and ultrasound characteristics of the carotid plaque in diabetic and non-diabetic patients. Ann Vasc Surg. 2019;61:218–26.
   PubMedGoogle Scholar
• Xiao H, Du A-M, Yun P, Zhang H-F, Tian Y, Xiao F-X. Prevalence and risk factors of chronic complications of type 2 diabetic inpatients in Hubei Province of central China: results from a multiple-hospital study. Int J Diabetes Dev Ctries. 2016;36(2):242–247.
   Google Scholar
• Gajardo-Navarrete J, Ibieta G, Concha M, et al. Coronary artery disease in pre and postmenopausal women. The influence of tune 2 diabetes mellitus. Rev Med Chil. 2020;148(2):145–150. doi:10.4067/s0034-98872020000200145
   PubMedGoogle Scholar
• Braga F, Pasqualetti S, Ferraro S, Panteghini M. Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis. Clin Chem Lab Med. 2016;54(1):7–15. doi:10.1515/cclm-2015-0523
   PubMed Web of Science ®Google Scholar
• Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. 2010;62(2):170–180.
   PubMed Web of Science ®Google Scholar
• Ito H, Abe M, Mifune M, et al. Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One. 2011;6(11):11. doi:10.1371/journal.pone.0027817
   Google Scholar
• Yang Y, Tian J, Zeng C, et al. Relationship between hyperuricemia and risk of coronary heart disease in a middle-aged and elderly Chinese population. J Int Med Res. 2017;45(1):254–260. doi:10.1177/0300060516673923
   PubMed Web of Science ®Google Scholar
• El-Mesallamy HO, Hamdy NM, Salman TM, Ibrahim SM. Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease. Angiology. 2012;63(2):96–102. doi:10.1177/0003319711408587
   PubMedGoogle Scholar
• Haider R, Hyun K, Cheung NW, Redfern J, Thiagalingam A, Chow CK. Effect of lifestyle focused text messaging on risk factor modification in patients with diabetes and coronary heart disease: a sub-analysis of the TEXT ME study. Diabetes Res Clin Pract. 2019;153:184–190. doi:10.1016/j.diabres.2019.04.030
   PubMedGoogle Scholar
• Edqvist J, Rawshani A, Adiels M, et al. Contrasting associations of body mass index and hemoglobin a1c on the excess risk of acute myocardial infarction and heart failure in type 2 diabetes mellitus. J Am Heart Assoc. 2019;8(24):e013871. doi:10.1161/JAHA.119.013871
   PubMed Web of Science ®Google Scholar
• Guo L, Cheng Y, Wang X, et al. Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol. 2012;49(S1):S65–S71. doi:10.1007/s00592-010-0205-5
   PubMedGoogle Scholar
• Yang Y, Huang B, Tan S, et al. Risk factor differences between type 2 diabetes patients with ischemic cerebrovascular versus coronary heart diseases at admission. J Diabetes Complications. 2015;29(6):783–787. doi:10.1016/j.jdiacomp.2015.04.016
   PubMedGoogle Scholar
• Malmberg K, Ryden L, Wedel H, et al. FASTTRACK intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26(7):650–661. doi:10.1093/eurheartj/ehi199
   PubMed Web of Science ®Google Scholar
• Ehara H, Yamamoto-Honda R, Kitazato H, et al. ApoE isoforms, treatment of diabetes and the risk of coronary heart disease. World J Diabetes. 2012;3(3):54–59. doi:10.4239/wjd.v3.i3.54
   PubMedGoogle Scholar
• Garg N, Moorthy N, Kapoor A, et al. Hemoglobin A(1c) in nondiabetic patients: an independent predictor of coronary artery disease and its severity. Mayo Clin Proc. 2014;89(7):908–916. doi:10.1016/j.mayocp.2014.03.017
   PubMed Web of Science ®Google Scholar
• Hsu WH, Lai CW, Chen SC, et al. Greater low-density lipoprotein cholesterol variability increases the risk of cardiovascular events in patients with type 2 diabetes mellitus. Endocr Pract. 2019;25(9):918–925. doi:10.4158/EP-2019-0002
   PubMed Web of Science ®Google Scholar
• Tehrani DM, Zhao YL, Blaha MJ, et al. Discordance of low-density lipoprotein and high-density lipoprotein cholesterol particle versus cholesterol concentration for the prediction of cardiovascular disease in patients with metabolic syndrome and diabetes mellitus (from the multi-ethnic study of atherosclerosis MESA). Am J Cardiol. 2016;117(12):1921–1927.
   PubMedGoogle Scholar
• Chin SO, Hwang JK, Rhee SY, et al. Risk factors for the progression of intima-media thickness of carotid arteries: a 2-year follow-up study in patients with newly diagnosed type 2 diabetes. Diabetes Metab J. 2013;37(5):365–374. doi:10.4093/dmj.2013.37.5.365
   PubMedGoogle Scholar
• Sun JT, Liu Y, Lu L, et al. Diabetes-invoked high-density lipoprotein and its association with coronary artery disease in patients with type 2 diabetes mellitus. Am J Cardiol. 2016;118(11):1674–1679. doi:10.1016/j.amjcard.2016.08.044
   PubMedGoogle Scholar
• Tolle M, Huang T, Schuchardt M, et al. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. Cardiovasc Res. 2012;94(1):154–162. doi:10.1093/cvr/cvs089
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Papageorgiou N, Androulakis E, et al. Diabetes mellitus-associated vascular impairment novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol. 2013;62(8):667–676. doi:10.1016/j.jacc.2013.03.089
   PubMedGoogle Scholar
• Cai H, Song CJ, Endoh I, et al. Serum amyloid A induces monocyte tissue factor. J Immunol. 2007;178(3):1852–1860. doi:10.4049/jimmunol.178.3.1852
   PubMedGoogle Scholar
• King DE, Mainous AG, Buchanan TA, Pearson WS. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care. 2003;26(5):1535–1539. doi:10.2337/diacare.26.5.1535
   PubMed Web of Science ®Google Scholar
• Wu G, Li G-B, Dai B, Zhang D-Q. Novel KIF6 polymorphism increases susceptibility to type 2 diabetes mellitus and coronary heart disease in Han Chinese men. J Diabetes Res. 2014;2014:1–8. doi:10.1155/2014/871439
   Google Scholar
• Fumisawa Y, Funase Y, Yamashita K, et al. Systematic analysis of risk factors for coronary heart disease in japanese patients with type 2 diabetes: a matched case-control study. J Atheroscler Thromb. 2012;19(10):918–923. doi:10.5551/jat.13334
   PubMedGoogle Scholar